Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Quarterly Trading Statement

24 Mar 2016 14:00

RNS Number : 2386T
Standard Life Euro Pri Eqty Tst PLC
24 March 2016
 

Standard Life European Private Equity Trust PLC

 

1. Investment update for the quarter from 1 October to 31 December 2015

 

· NAV increased 3.5% to 291.5p for the quarter ended 31 December 2015

· Realised gains and income were £24.0 million (6.5% of opening portfolio valuation). The unrealised losses on the portfolio on a constant exchange rate basis were £11.1 million (3.0% of opening portfolio valuation); in addition, there were unrealised foreign exchange gains on the portfolio of £1.1 million (0.3% of opening portfolio valuation)

· 100.0% by value of the portfolio was valued by the respective underlying managers at 31 December 2015

· Outstanding commitments were £240.0 million at 31 December 2015

· Cash balance was £40.5 million and £39.3 million was invested in equity index tracker funds at 31 December 2015

 

For the quarter ended 31 December 2015 the Company's net asset value per ordinary share ("NAV") increased by 3.5% to 291.5p, from 281.6p at 30 September 2015. At 31 December 2015 the Company's net assets were £454.1 million (30 September 2015 - £438.7 million).

 

In light of the volatile listed financial markets and a weakening global macro-economic environment, the quarter ended 31 December 2015 saw a decrease in new investment activity in the European private equity market. The value of all new private equity transactions in the European private equity market announced during the quarter was €35.8 billion (quarter ended 30 September 2015 - €40.5 billion), of which €29.4 billion comprised buy-out transactions (quarter ended 30 September 2015 - €34.2 billion).

 

Distributions received by the Company during the quarter ended 31 December 2015 were £45.1 million (quarter ended 30 September 2015 - £34.6 million) and the Company funded £17.0 million of draw downs (quarter ended 30 September 2015 - £12.0 million). The distributions received by the Company generated net realised gains and income of £24.0 million, which was equivalent to a return of 2.1 times the acquisition cost of the realised investments.

 

The closing value of the Company's portfolio of 47 private equity fund interests was £373.9 million at 31 December 2015 (30 September 2015 - 46 fund interests and £369.0 million). Total net unrealised losses on the portfolio for the quarter were £10.0 million, of which £11.1 million were net unrealised losses on a constant exchange rate basis and £1.1 million were net unrealised foreign exchange gains. During the quarter ended 31 December 2015, sterling was flat against the euro and depreciated by 2.7% against the US dollar.

 

In line with the Company's investment strategy, the Company acquired through a secondary purchase an original commitment of $60.0 million to TowerBrook Investors III in December 2015. The purchase price for the fund interest was £19.1 million, equivalent to a discount of 6.1% to the most recent valuation at 30 September 2015, adjusted for subsequent cashflows. The Company assumed outstanding commitments of £10.8 million on acquisition. The Company does not have an existing commitment to TowerBrook Investors III, but has existing commitments of $25.0 million and $35.0 million to TowerBrook Investors II and IV respectively.

 

At 31 December 2015 the Company had a cash balance of £40.5 million and had £39.3 million invested at value (£39.2 million at cost) in UK and European equity index tracker funds. The Company has an undrawn £80 million syndicated revolving credit facility, provided by Citi and Societe Generale, that expires in December 2020.

 

At 31 December 2015 the Company had total outstanding commitments of £240.0 million to 47 private equity fund interests (30 September 2015 - £245.8 million and 46 fund interests). After undertaking a detailed review, the Manager now believes that up to £55 million of the Company's existing outstanding commitments are unlikely to be drawn (30 September 2015 - £50 million).

 

2. Events and transactions since 1 January 2016

 

During the period from 1 January to 23 March 2016 the Company received £29.2 million of distributions and funded £16.0 million of draw downs.

 

A new commitment of €45.0 million was made to Advent International GPE VIII in February 2016. At 23 March 2016 the Company had total outstanding commitments of £271.4 million.

 

On 29 January 2016 the Company paid a final dividend for the year ended 30 September 2015 of 3.5p per ordinary share (total for the year of 5.25 pence per share). The cost of the final dividend was £5.5 million.

 

At 23 March 2016 the Company had a cash balance of £50.1 million and had £39.7 million invested at value (£39.2 million at cost) in UK and European equity index tracker funds.

 

The Company's estimated NAV at 29 February 2016 is also being announced today. It is anticipated that the Company will release its interim announcement for the six months ending 31 March 2016 on 27 May 2016.

 

For further information please contact:-

 

Peter McKellar or Roger Pim at SL Capital Partners LLP (0131 245 0055)

 

Note:-

Standard Life European Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under section 1158 of the Corporation Tax Act 2010. The Board of Standard Life European Private Equity Trust PLC is independent of Standard Life plc.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCXZLFLQXFXBBL
Date   Source Headline
1st Jul 200911:19 amRNSTotal Voting Rights
30th Jun 20093:31 pmRNSDirector/PDMR Shareholding
26th Jun 20099:00 amRNSIssue of Equity
9th Jun 200912:17 pmRNSDirector/PDMR Shareholding
3rd Jun 20092:22 pmRNSDirector/PDMR Shareholding
2nd Jun 200910:20 amRNSDirector/PDMR Shareholding
29th May 20097:00 amRNSHalf Yearly Report
24th Mar 20097:30 amRNSTrading Statement
24th Feb 200910:15 amRNSSecondary Sales
3rd Feb 20092:37 pmRNSHolding(s) in Company
2nd Feb 200912:37 pmRNSDirector/PDMR Shareholding
2nd Feb 200912:34 pmRNSDirector/PDMR Shareholding
2nd Feb 200912:30 pmRNSTotal Voting Rights
2nd Feb 200911:23 amRNSHolding(s) in Company
27th Jan 200910:10 amRNSIssue of Shares following Scrip Dividend
26th Jan 20094:20 pmRNSInterim Management Statement
26th Jan 20094:08 pmRNSResult of AGM
26th Jan 200912:19 pmRNSDirectorate Change
14th Jan 20097:00 amRNSDisposal of Private Equity Fund Interests
8th Jan 20093:00 pmRNSScrip Dividend reference price
5th Jan 20094:05 pmRNSAnnual Financial Report
5th Jan 20094:00 pmRNSAnnual Information Update
18th Dec 20084:00 pmRNSAppointment of Broker
18th Dec 200811:46 amRNSDirector/PDMR Shareholding
17th Dec 20082:43 pmRNSDoc re. Annual Report
4th Dec 20084:49 pmRNSDirector/PDMR Shareholding
1st Dec 20087:00 amRNSFinal Results
27th Nov 20082:21 pmRNSDirectorate Change
23rd Sep 20087:00 amRNS3rd Quarter Trading Statement
22nd Sep 20082:37 pmRNSResult of EGM
22nd Aug 20087:00 amRNSCircular re EGM
30th Jul 20084:42 pmRNSSecond Price Monitoring Extn
30th Jul 20084:36 pmRNSPrice Monitoring Extension
24th Jul 20087:30 amRNSInterim Management Statement
15th Jul 20084:37 pmRNSDirector/PDMR Shareholding
30th Jun 200810:16 amRNSDirector Declaration
17th Jun 20084:22 pmRNSDoc re. Interim Report
30th May 20087:00 amRNSInterim Results
20th May 20083:18 pmRNSHolding(s) in Company
18th Mar 20082:58 pmRNSDirector/PDMR Shareholding
18th Mar 20087:00 amRNSTrading Statement
30th Jan 200810:31 amRNSDirector/PDMR Shareholding
29th Jan 20089:00 amRNSInterim Management Statement
28th Jan 20084:20 pmRNSResult of AGM
10th Jan 200810:31 amRNSAnnual Information Update
3rd Jan 200810:23 amRNSPortfolio Update
3rd Jan 200810:21 amRNSTotal Voting Rights
27th Dec 200710:33 amRNSDirector/PDMR Shareholding
20th Dec 20072:00 pmRNSDoc re. Annual Report
28th Nov 20077:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.